Targeting of stealth liposomes to erbB-2 (Her/2) receptor: In vitro and in vivo studies

British Journal of Cancer

Volumn 74, Issue 11, 1996, Pages 1749-1756

  Goren, D ^a   Horowitz, A T ^a   Zalipsky, S ^b   Woodle, M C ^b   Yarden, Y ^c   Gabizon, A ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b ALZA CORPORATION   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Chemotherapy; erbB 2; Liposomes; Monoclonal antibodies; Targeting

Indexed keywords

CELL RECEPTOR; DOXORUBICIN; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CIRCULATION TIME; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TARGETING; DRUG UPTAKE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; ONCOGENE NEU; OVARY CARCINOMA; PRIORITY JOURNAL; RECEPTOR AFFINITY; RETICULOENDOTHELIAL SYSTEM;

EID: 0029828939     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.625     Document Type: Article

References (37)

1. AHMAD I AND ALLEN TM. (1992). Antibody-mediated specific binding and cytotoxicity of liposome entrapped doxorubicin to lung cancer cells in vitro. Cancer Res., 52, 4817-4820.
2. AHMAD I, LONGENECKER M, SAMUEL J AND ALLEN TM. (1993). Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res., 53, 1484-1488.
3. ALLEN TM, AGRAWAL AK, AHMAD I, HANSEN CB AND ZALIPSKY S. (1994). Antibody-mediated targeting of long circulating (Stealth) liposomes. J. Liposome Res., 4, 1-25.
4. BACUS SS, STANCOVSKI I, HUBERMAN E, CHIN D, HURWITZ E, MILLS GB, ULLRICH A, SELA M AND YARDEN Y (1992). Tumor inhibitory monoclonal antibodies to the HER-2/neu receptor, induce differentiation of human breast cancer cells. Cancer Res., 52, 2580-2589.
5. HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol., 14, 737-744.
6. BERCHUCK A, KAMEL A, WHITAKER R, KERNS B, OLT G, KINNEY R, SOPER JT, DODGE R, CLARKE-PEARSON DL AND MARKS P. (1990). Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res., 50, 4087-4091.
7. BURROWS FJ AND THORPE PE. (1993). Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc. Natl Acad. Sci. USA, 90, 8996-9000.
8. DEBS RJ, HEATH TD AND PAPAHADJOPOULOS D. (1987). Targeting of anti-thy 1.1 monoclonal antibody- conjugated liposomes in Thy 1.1 mice after intravenous administration. Biochim. Biophys. Acta, 901, 183-190.
9. EMANUEL N, KEDAR E, BOLOTIN EM, SMORODINSKY NI AND BARENHOLZ Y. (1996). Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing mice. Pharm. Res., 13, 861-868.
10. GABIZON A. (1992). Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long circulating liposomes. Cancer Res., 52, 891-896.
11. GABIZON A, PRICE DC, HUBERTY J, BRESALIER RS AND PAPAHADJOPOULOS D. (1990). Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res., 50, 6371-6378.
12. HARRIS DT AND MASTRANGELO MJ. (1989). Serotherapy of cancer. Semin. Oncol., 16, 180-198.
13. HARWERTH IM, WELS W, SCHLEGEL J, MUELLER M AND HYNES NE. (1993). Monoclonal antibodies directed to the erB-2 receptor inhibit in vivo tumour cell growth. Br. J. Cancer, 68, 1140-1145
14. HOROWITZ AT, TREVES AJ, VOSS R, OKON E, FUKS Z, DAVIDSON L AND BIRAN S. (1985). A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers. Oncology, 42, 332-337.
15. HOROWITZ AT, BARENHOLZ Y AND GABIZON A. (1992). In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release. Biochim. Biophys. Acta, 1109, 203-209.
16. HUANG SK, HONG K, LEE KD, PAPAHADJOPOULOS D AND FRIEND DS. (1991). Light microscopic localization of silver enhanced liposome entrapped colloidal gold in mouse tissues. Biochim. Biophys. Acta, 1069, 117-121.
17. HUANG SK, MARTIN FJ, JAY G, VOGEL J, PAPAHADJOPOULOS D AND FRIEND DS. (1993). Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice hearing the HIV tat gene. Am. J. Pathol., 143, 10-14.
18. HURWITZ E, STANCOVSKI I, SELA M AND YARDEN Y. (1995). Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake. Proc. Natl Acad. Sci. USA, 92, 3353-3357.
19. JAIN RK. (1989). Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. Natl Cancer Inst., 81, 570-576.
20. 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts. Cancer Res., 45, 5700-5706.
21. LEE RJ AND LOW PS. (1995). Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta, 1233, 134-144.
22. PAPAHADJOPOULOS D, ALLEN TM, GABIZON A, MAYHEW E, MATTAY K, HUANG SK, WOODLE MC, LASIC DD, REDEMANN C AND MARTIN FJ. (1991). Sterically stabilized liposomes: improvements in pharmacokinetics and anti-tumor therapeutic efficacy. Proc. Natl Acad. Sci. USA, 88, 11460-11464.
23. PARK JG, FRUCHT H, LAROCCA RV, BLISS DPJ, KURITA Y, CHEN TR, HENSLEE JG, TREPEL JB, JENSEN RT, JOHNSON BE, BANG YJ, KIM JP AND GAZDAR AF. (1990). Characteristics of cell lines established from human gastric carcinoma. Cancer Res., 50, 2773-2780.
24. PARK JW, STAGG R, LEWIS GD, CARTFR P, MANEVAL D, SLAMON DJ, JAFFE H AND SHEPARD HM. (1992). Advances in cellular and molecular biology of breast cancer. In Genes, Oncogenes, Hormones, Dickson RB and Lippman ME. (eds) pp. 193-211. Kluwer Academic Publishing: Boston.
25. HER2 immunoliposomes for cancer therapy. Proc. Natl Acad. Sci. USA, 92, 1327-1331.
26. PEETERS PA, BRUNINK BG, ELING WM AND CROMMELIN DJ. (1989). Therapeutic effect of chloroquine (CQ)-containing immunoliposomes in rats infected with Plasmodium berghe: parasitized mouse red blood cells: comparison with combination of antibodies and CQ or liposomal CQ. Biochim. Biophys. Acta. 981, 269-276.
27. PRESS MF, CORDON-CARDO C AND SLAMON DJ. (1990). Expression of the HER-2/neu proto-oncogene in normal human adults and fetal tissues. Oncogene, 5, 953-962.
28. SLAMON DJ, CLARK GM, WONG SG, LEVIN WJ, ULLRICH A AND McGUIRE WL. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2 neu oncogene. Science, 235, 177-182.
29. SLAMON DJ, GODOLPHIN W, JONES LA, HOLT JA, WONG SG, KEITH DE, LEVIN WJ, STUART SG, UDOVE J, ULLRICH A AND PRESS MF. (1989). Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science, 244, 707-712.
30. STANCOVSKI I, HURWITZ E, LEITNER O, ULLRICH A, YARDEN Y AND SELA M. (1991). Mechanistic aspects of the opposing effects of monoclonal antibodies to the erbB-2 receptor on tumor growth. Proc. Natl Acad. Sci. USA, 88, 8691-8695.
31. UZIELY B, JEFFERS S, ISACSON R, KUTSCH K, WEI-TSAO D, YEHOSHUA Z, MUGGIA FM AND GABIZON A. (1995). Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J. Clin. Oncol., 13, 1777-1785.
32. VAAGE J, BARBERA-GUILLEM E, ABRA R, HUANG A AND WORKING P. (1994). Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal Doxorubicin on human prostate carcinoma xenografts. Cancer, 73, 1478-1484.
33. WILLIAMS SS, ALOSCO TR, MAYHEW E, LASIC DD, MARTIN FJ AND BANKERT RB. (1993). Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using Doxorubicin encapsulated in sterically stabilized liposomes. Cancer Res., 53, 3964-3967.
34. YONEMURA Y, NINOMIYA I, YAMAGUCHI A, FUSHIDA S, KIMURA H, OHOYAMA S, MIYAZAKI I, ENDOU Y, TANAKA M AND SASAKI T. (1991). Evaluation of immunoreactivity for erbB2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res., 51, 1034-1038.
35. ZALIPSKY S. (1993a). Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. Bioconjug. Chem., 4, 296-299.
36. ZALIPSKY S, NEWMAN M, PUNTAMBEKAR B AND WOODLE MC. (1993A). Model ligands linked to the polymer-chains on liposomal surfaces: application of a new functionalized polyethylene glycol lipid conjugate. Polym. Mater. Sci. Eng., 67, 519-520.
37. ZALIPSKY S, PUNTAMBEKAR B, BOULIKAS P, ENGBERS CM AND WOODLE MC. (1995). Peptide attachment to extremities of liposomal surface grafted PEG chains: preparation of the long-circulating form of laminin pentapeptide, YIGSR. Bioconjugate Chem., 6, 705-708.